secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2022-06-06T23:59:59+00:00
Accession:  0001193125-22-167951
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mirum appoints Saira Ramasastry to board; stockholders re-elect three directors
-------------------------------------------------------------------------------

- Saira Ramasastry appointed to Mirum's board effective June 2, 2022; will serve on audit committee.
- Ramasastry received option to purchase 34,000 shares vesting over three years; annual cash retainers of $40k (board) and $10k (audit).
- At annual meeting, stockholders re-elected directors Laura Brege, Michael Grey, and Christopher Peetz to Class III terms expiring 2025.
- Stockholders ratified Ernst & Young as independent auditor for FY2022 with overwhelming support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000119312522167951/0001193125-22-167951-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000119312522167951/d309554d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-167951

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer